Sava Raises $36M Series A+ Led by Ascensia Diabetes Care

Sava raises $36M Series A+ led by Ascensia Diabetes Care.

Participants in this funding round include Balderton Capital, Pentland Ventures, Norrsken VC, Simplyhealth Ventures, and JamJar Investments. This investment is aimed at expanding manufacturing capabilities and preparing for a commercial launch before a pivotal study commences.

Sava develops multi-analyte glucose microsensors aimed at replacing fingerstick glucose testing. The company is led by CEO Renato Circi.

Company	Sava
Round	Series A+
Amount	$36M
Lead Investor	Ascensia Diabetes Care
Investors	Balderton Capital, Pentland Ventures, Norrsken VC, Simplyhealth Ventures, JamJar Investments
Founders	Renato Circi, Rafaël Michali
Sectors	Medtech